Key result
Corrigendum updates graphical abstract comparing DOACs and warfarin in end-stage kidney disease with AF.
This is a corrigendum revising the graphical abstract for a study comparing the efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Corrigendum to graphical abstract leaves conclusions unchanged; observational data on anticoagulation in end-stage kidney disease with AF remain hypothesis-generating.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied End-stage kidney disease and atrial fibrillation. Direct oral anticoagulants (DOACs) vs. Warfarin was evaluated. Direct oral anticoagulants and warfarin were evaluated in a corrigendum updating the graphical abstract for patients with end-stage kidney disease and atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: